healthy subjects
Conditions
Interventions
Continuous intake of the test food(placebo, two tablets per day) for 12 weeks
Continuous intake of the test food(active, two tablets per day) for 12 weeks
Sponsors
UHA Mikakuto Co.,Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Japanese men aged 50 to 59 at the time of obtaining consent. 2)Those who can submit a total of 60 hair strands, with at least 20 strands each from the back, top, and sides of the head, cut from the root to about 1 cm, on 2 times: during screening and at the end of this study. The hair can be cut by themselves or by a family member. 3)Individuals with a BMI ranging from 18 to 29.9 (men).
Exclusion criteria
Exclusion criteria: 1)Those who have had or plan to have a haircut, perm, grey hair dyeing, and coloring within 4 weeks prior to the screening date and the final observation date of this study (this is allowed if it occurs between the screening and 4 weeks prior to the final observation date). 2)Those who are currently undergoing treatment for depression or other psychiatric disorders. 3) Those who are currently undergoing treatment for adrenal dysfunction (e.g., those with collagen diseases and rheumatoid arthritis being treated with steroids). 4) Those who are undergoing treatment with oral and topical glucocorticoids (such as hydrocortisone esters and prednisolone). 5)Those who are undergoing treatment for thyroid disorders. 6)Those who are undergoing treatment for LOH (Late-Onset Hypogonadism) syndrome at medical institutions such as specialized clinics (including testosterone replacement therapy). 7)Those who have taken 5-alpha reductase inhibitors (medications for AGA) within the past 6 months. 8)Individuals taking supplements containing minerals (such as zinc and multiminerals). 9)Those who are using shampoos containing minerals (such as zinc and seaweed).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Testosterone and zinc levels in hair | — |
Countries
Japan
Contacts
Public ContactMami Kishida
UHA Mikakuto Co.,Ltd. Global Healthcare Research Laboratory
Outcome results
None listed